Pretreatment Serum Fibrinogen Levels are Associated with Postoperative Distant Metastasis and Prognosis of Resected Lung Cancer Patient: A Retrospective Study

Title:Pretreatment Serum Fibrinogen Levels are Associated with Postoperative Distant Metastasis and Prognosis of Resected Lung Cancer Patient: A Retrospective Study

Volume: 12 Issue: 1

Author(s): Effat Un Nesa, Muhammad Shahbaz, Cong Wang, Han Zhang, Xiao Y. Liu, Ying Sun, Li Jingyi, Muhammad Ijaz, Tamanna Khanam, Peng X. Chen and Yufeng Cheng*

Affiliation:

• Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong 250012,China

Keywords: Lung cancer, hyperfibrinogenemia, prognosis, metastasis, relapse, plasma fibrinogen level, lymph node status.

Abstract: Objective: Lung cancer is one of the main causes of cancer-related mortality. The identification of early diagnostic biomarkers improved outcomes for lung cancer patients. This study investigated the correlation of preoperative plasma fibrinogen level with distant metastasis and prognosis in lung cancer patients.

Methods: A total of 139 lung cancer patients who underwent curative surgery between January 2009 and November 2010 were enrolled in this study. In addition to clinical and pathological prognostic factors, we evaluated the prognostic value of plasma fibrinogen on distant metastasis and relapse. Univariate analysis was performed using the Kaplan-Meier survival analysis and multivariate analysis was performed using the Cox regression model in order to measure 5-year distant metastasisfree survival (DMFS), locoregional relapse-free survival (LRFS), relapse-free survival (RFS), and overall survival (OS).

Results: Median plasma fibrinogen level was 3.59 g/L (range: 1.92-8.73 g/L). A total of 86 patients (61.9%) had normal plasma fibrinogen levels (<4 g/L) and 53 patients (38.1%) had hyperfibrinogenemia (>4 g/L). Pearson’s chi-square test showed that plasma fibrinogen level was significantly associated with age (P=0.047), tumor stage (P<0.001), and lymph node status (P=0.037) whereas there was no significant association between plasma fibrinogen level and gender, smoking, alcohol, tumor size, and tumor differentiation. Median follow-up time was 37 months. The 5-year DMFS, LRMFS, RFS, and OS rates were 26.40, 18.90, 7.50, and 28.30% with hyperfibrinogenemia respectively. Multivariate analysis showed that lymph node status (P=0.001, HR=0.397 with 95% CI=0.233-0.677) and plasma fibrinogen level (P=0.002, HR=0.410 with 95% CI=0.234-0.718) were significantly related to LRFS. RFS was significantly related to plasma fibrinogen level (P=0.036, HR=0.596 with 95% CI=0.368- 0.966) and lymph node status (P<0.001, HR=0.405 with 95% CI=0.260-0.631). DMFS was also significantly related to lymph node stage (P=0.006, HR=0.501 with 95% CI=0.307-0.817) and plasma fibrinogen level (P=0.001, HR=0.399 with 95% CI=0.236-0.674).

Conclusion: Preoperative increased plasma fibrinogen level was a predictor of distant metastasis and was independently associated with the prognosis of lung cancer patients.

Cite this article as:

Nesa Effat Un, Shahbaz Muhammad, Wang Cong, Zhang Han, Liu Y. Xiao, Sun Ying, Jingyi Li, Ijaz Muhammad, Khanam Tamanna, Chen X. Peng and Cheng Yufeng*, Pretreatment Serum Fibrinogen Levels are Associated with Postoperative Distant Metastasis and Prognosis of Resected Lung Cancer Patient: A Retrospective Study, Current Signal Transduction Therapy 2017; 12 (1) . https://dx.doi.org/10.2174/1574362412666170126161936

DOI https://dx.doi.org/10.2174/1574362412666170126161936	Print ISSN 1574-3624
Publisher Name Bentham Science Publisher	Online ISSN 2212-389X